1. Home
  2. XLO vs RCON Comparison

XLO vs RCON Comparison

Compare XLO & RCON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.57

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Logo Recon Technology Ltd.

RCON

Recon Technology Ltd.

HOLD

Current Price

$1.25

Market Cap

46.9M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
RCON
Founded
2016
2007
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oilfield Services/Equipment
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
41.8M
46.9M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
XLO
RCON
Price
$0.57
$1.25
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
572.5K
7.7K
Earning Date
03-10-2026
10-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$31,804,000.00
$9,252,775.00
Revenue This Year
$626.78
N/A
Revenue Next Year
$79.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
588.40
N/A
52 Week Low
$0.50
$1.13
52 Week High
$1.70
$7.16

Technical Indicators

Market Signals
Indicator
XLO
RCON
Relative Strength Index (RSI) 45.49 38.19
Support Level $0.50 $1.22
Resistance Level $0.61 $1.31
Average True Range (ATR) 0.04 0.08
MACD 0.00 -0.01
Stochastic Oscillator 55.80 6.15

Price Performance

Historical Comparison
XLO
RCON

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

About RCON Recon Technology Ltd.

Recon Technology Ltd provides automation systems, industrial equipment, and support services tailored for the oil and gas industry in China. The company's business spans key segments such as automation products and software, equipment and accessories, oilfield environmental protection, and platform outsourcing services. It generates the majority of its revenue by providing integrated automation services to Chinese petroleum companies at oilfields. Its key products and services include pumping unit controllers, natural gas flow computer systems, wireless dynamometers and wireless pressure gauges, and an oilfield monitor and data acquisition system. The company's operations are centered on servicing upstream clients throughout China, with some broader industrial automation solutions.

Share on Social Networks: